Sichuan Hebang Revenue vs. Market Capitalization
603077 Stock | 1.99 0.02 1.00% |
Total Revenue | First Reported 2012-09-30 | Previous Quarter 2.8 B | Current Value 2 B | Quarterly Volatility 918 M |
For Sichuan Hebang profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sichuan Hebang to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sichuan Hebang Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sichuan Hebang's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sichuan Hebang Biotechnology over time as well as its relative position and ranking within its peers.
Sichuan |
Sichuan Hebang Biote Market Capitalization vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sichuan Hebang's current stock value. Our valuation model uses many indicators to compare Sichuan Hebang value to that of its competitors to determine the firm's financial worth. Sichuan Hebang Biotechnology is rated below average in revenue category among its peers. It also is rated below average in market capitalization category among its peers creating about 2.00 of Market Capitalization per Revenue. At present, Sichuan Hebang's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Sichuan Hebang by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sichuan Hebang's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sichuan Revenue vs. Competition
Sichuan Hebang Biotechnology is rated below average in revenue category among its peers. Market size based on revenue of Materials industry is presently estimated at about 1.05 Trillion. Sichuan Hebang maintains roughly 8.82 Billion in revenue contributing less than 1% to all equities under Materials industry.
Sichuan Market Capitalization vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Sichuan Hebang |
| = | 8.82 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Sichuan Hebang |
| = | 17.66 B |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Sichuan Market Capitalization vs Competition
Sichuan Hebang Biotechnology is rated below average in market capitalization category among its peers. Market capitalization of Materials industry is presently estimated at about 1.19 Trillion. Sichuan Hebang claims roughly 17.66 Billion in market capitalization contributing just under 2% to all equities under Materials industry.
Sichuan Hebang Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sichuan Hebang, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sichuan Hebang will eventually generate negative long term returns. The profitability progress is the general direction of Sichuan Hebang's change in net profit over the period of time. It can combine multiple indicators of Sichuan Hebang, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Operating Income | 1.5 B | 1.1 B | |
Income Before Tax | 1.5 B | 1 B | |
Net Income Applicable To Common Shares | 4.4 B | 4.6 B | |
Net Income | 1.3 B | 862.7 M | |
Income Tax Expense | 768.6 M | 807 M | |
Net Income From Continuing Ops | 1.3 B | 1.2 B | |
Total Other Income Expense Net | -173.3 M | -164.7 M | |
Net Interest Income | 34.4 M | 36.1 M | |
Interest Income | 60.4 M | 63.4 M | |
Change To Netincome | 97.1 M | 81.7 M |
Sichuan Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sichuan Hebang. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sichuan Hebang position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sichuan Hebang's important profitability drivers and their relationship over time.
Use Sichuan Hebang in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sichuan Hebang position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sichuan Hebang will appreciate offsetting losses from the drop in the long position's value.Sichuan Hebang Pair Trading
Sichuan Hebang Biotechnology Pair Trading Analysis
The ability to find closely correlated positions to Sichuan Hebang could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sichuan Hebang when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sichuan Hebang - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sichuan Hebang Biotechnology to buy it.
The correlation of Sichuan Hebang is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sichuan Hebang moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sichuan Hebang Biote moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sichuan Hebang can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sichuan Hebang position
In addition to having Sichuan Hebang in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in Sichuan Stock
To fully project Sichuan Hebang's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sichuan Hebang Biote at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sichuan Hebang's income statement, its balance sheet, and the statement of cash flows.